Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-03-12

FDA Approved: MESALAMINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Mesalamine from Teva Pharmaceuticals USA, Inc., updating the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesalamine (Mesalamine)

Snippet

SUPPL AP for MESALAMINE (MESALAMINE)